Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression

por Harahap, Agnes Stephanie, Subekti, Imam, Panigoro, Sonar Soni, Asmarinah, Lisnawati, Werdhani, Retno Asti, Agustina, Hasrayati, Khoirunnisa, Dina, Mutmainnah, Mutiah, Gultom, Fajar Lamhot, Assadyk, Abdillah Hasbi, Ham, Maria Francisca
Publicado 2023

Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy

por Hamid, Agus Rizal A. H., Kusuma Putra, Harun W., Sari, Ningrum Paramita, Diana, Putri, Sesari, Saras Serani, Novita, Eka, Gultom, Fajar Lamhot, Saraswati, Meilania, Tanurahardja, Budiana, Asmarinah, Umbas, Rainy, Mochtar, Chaidir A.
Publicado 2020